Literature DB >> 29745323

Research Progress on Brucellosis.

Yuming Deng1, Xinyue Liu1, Kaifang Duan1, Qisheng Peng1.   

Abstract

Brucellosis is a debilitating febrile illness caused by an intracellular Brucella. The disease is distributed in humans and animals widely, especially in developing countries. Ten species are included in the genus Brucella nowadays; four species of them are pathogenic to humans, which make brucellosis a zoonosis with more than 500,000 new cases reported annually. For human brucellosis, the most pathogenic species is B. melitensis followed by B. suis, while B. abortus is the mildest type of brucellosis. The infection mechanism of Brucella is complicated and mostly relies on its virulence factors. The therapy of the disease contains vaccination and antibiotic. However, there are some defects in currently available vaccines such as the lower protective level and safety. Thus, safe and efficient vaccines for brucellosis are still awaited. The dual therapy of antibacterial is effective in the treatment of brucellosis if a rapid and exact detection method is found. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Brucella; brucellosis; febrile illness; genus; pathogen; treatment; zoonosis.

Mesh:

Substances:

Year:  2019        PMID: 29745323     DOI: 10.2174/0929867325666180510125009

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  10 in total

1.  Identification of cerebrospinal fluid metabolites as biomarkers for neurobrucellosis by liquid chromatography-mass spectrometry approach.

Authors:  Hao Yang; Zhenfei Wang; Shujun Shi; Qin Yu; Meiling Liu; Zhelin Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

2.  Clinical Effect of Doxycycline Combined with Compound Sulfamethoxazole and Rifampicin in the Treatment of Brucellosis Spondylitis.

Authors:  Xin-Ming Yang; Yong-Li Jia; Ying Zhang; Pei-Nan Zhang; Yao Yao; Yan-Lin Yin; Ye Tian
Journal:  Drug Des Devel Ther       Date:  2021-11-23       Impact factor: 4.162

3.  Oral S2-Ag85 DNA Vaccine Activated Intestinal Cell dsDNA and RNA Sensors to Promote the Presentation of Intestinal Antigen.

Authors:  Dang Sheng; Sui Xin; Wu Dongxing; Wen Shubo; Song Yang; Chen Zeliang; Zhai Jingbo
Journal:  J Immunol Res       Date:  2022-04-13       Impact factor: 4.493

4.  Early diagnosis and treatment of acute brucellosis knee arthritis complicated by acute osteomyelitis: two cases report.

Authors:  Jie Wang; Qiang Zhang
Journal:  BMC Infect Dis       Date:  2022-05-04       Impact factor: 3.667

5.  Epidemic characteristics and transmission risk prediction of brucellosis in Xi'an city, Northwest China.

Authors:  Chenxi Zhao; Kun Liu; Chenghao Jiang; Xiao Wei; Shuxuan Song; Xubin Wu; Xiaohui Wen; Ting Fu; Li Shen; Zhongjun Shao; Qian Li
Journal:  Front Public Health       Date:  2022-07-22

6.  Femoral Head Necrosis Due to Brucella Infection in China: Case Series and Literature Review.

Authors:  Jie Wang; Yao Zhang; Changsong Zhao; Qiang Zhang
Journal:  Infect Drug Resist       Date:  2022-10-10       Impact factor: 4.177

7.  Predictive analysis of the number of human brucellosis cases in Xinjiang, China.

Authors:  Yanling Zheng; Liping Zhang; Chunxia Wang; Kai Wang; Gang Guo; Xueliang Zhang; Jing Wang
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

8.  Evaluating active versus passive sources of human brucellosis in Jining City, China.

Authors:  Xihong Sun; Wenguo Jiang; Yan Li; Xiuchun Li; Qingyi Zeng; Juan Du; Aitian Yin; Qing-Bin Lu
Journal:  PeerJ       Date:  2021-06-22       Impact factor: 2.984

9.  Comparative Evaluation of Nested Polymerase Chain Reaction for Rapid Diagnosis of Human Brucellosis.

Authors:  L Rahbarnia; S Farajnia; B Naghili; N Saeedi
Journal:  Arch Razi Inst       Date:  2021-06-30

10.  Epidemiological, Clinical and Laboratory Characteristics of Patients with Brucella Infection in Anhui Province, China.

Authors:  Cuixiao Shi; Lianzi Wang; Dongmei Lv; Gang Wang; Hylemariam Mihiretie Mengist; Tengchuan Jin; Bo Wang; Ying Huang; Yajuan Li; Yuanhong Xu
Journal:  Infect Drug Resist       Date:  2021-07-16       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.